PASITHEA THERAPEUTICS CORP's ticker is and the CUSIP is 70261F103. A total of 10 filers reported holding PASITHEA THERAPEUTICS CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,439 | -2.1% | 3,000 | 0.0% | 0.00% | – |
| Q2 2023 | $1,470 | +47.0% | 3,000 | 0.0% | 0.00% | – |
| Q1 2023 | $1,000 | +49900.0% | 3,000 | 0.0% | 0.00% | – |
| Q4 2022 | $2 | -99.8% | 3,000 | +200.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| K2 PRINCIPAL FUND, L.P. | 491,797 | $497,000 | 0.06% |
| Virtu Financial LLC | 14,571 | $15,000 | 0.00% |
| VANGUARD GROUP INC | 78,139 | $79,000 | 0.00% |
| UBS Group AG | 12,805 | $13,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 95 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 19,726 | $19,000 | 0.00% |
| STATE STREET CORP | 23,647 | $24,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 2,254 | $2,000 | 0.00% |
| JPMORGAN CHASE & CO | 1,000 | $1,000 | 0.00% |